CLINICAL_TRIALS
trial_result
· 2024-03-20
Clinical Trial Update: Efficacy and Safety of IVM/ALB Co-administration [Phase 2, Phase 3]
Summary
Phase 2/Phase 3 trial update on efficacy and safety of ivermectin/albendazole co-administration for trichuriasis, with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jennifer Keiser | Conditions: Trichuriasis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-03-20